Evidence map›Paper›PMID 32717380›Full record

Observational studyThe ocular surface2020

Assessing the ocular surface microbiome in severe ocular surface diseases.

Michael J Zilliox, William S Gange, Gina Kuffel, Carine R Mores, Cara Joyce, Paul de Bustros, Charles S Bouchard

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in The ocular surface, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Editorial: Ocular surface disorders- an insight.Frontiers in ophthalmology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Toward the Characterization of the Human Core Ocular Surface Microbiome.Investigative ophthalmology & visual science · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Ocular surface microbiota alterations in patients with pterygium.Frontiers in cellular and infection microbiology · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michael J ZillioxDepartment of Public Health Sciences, Loyola University Chicago, 2160 South First Avenue, Maywood, IL, 60153, USA.
William S GangeDepartment of Ophthalmology, Loyola University Medical Center, USA.
Gina KuffelDepartment of Public Health Sciences, Loyola University Chicago, 2160 South First Avenue, Maywood, IL, 60153, USA.
Carine R MoresDepartment of Biology, Loyola University Chicago, 1032 Sheridan Rd, Chicago, IL, 60660, USA.
Cara JoyceDepartment of Biology, Loyola University Chicago, 1032 Sheridan Rd, Chicago, IL, 60660, USA.
Paul de BustrosLoyola Stritch School of Medicine, USA.
Charles S BouchardDepartment of Ophthalmology, Loyola University Medical Center, USA. Electronic address: cboucha@lumc.edu.
Loyola University Chicago · USLoyola University Medical Center · US

Funding

Summer Research Experience for Medical Students in Inflammation and Infectious DiseasesT35AI125220 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI Edward M. Campbell, Simon Kaja · 2017 to 2026
$510k
NIAID NIH HHS T35 AI125220
6 · The paper itself

Abstract

purposeThere is growing evidence for a critical role of the microbiome in ocular health and disease. We performed a prospective, observational study to characterize the ocular surface microbiome (OSM) in four chronic ocular surface diseases (OSDs) and healthy controls.

methodsSterile swabs were used to collect samples from each eye of 39 patients (78 eyes). Sterile technique and multiple controls were used to assess contamination during DNA extraction, amplification and sequencing. Concurrent use of topical antibiotics, steroids, and bandage contact lenses (BCLs) was documented.

resultsDespite the low biomass of the ocular surface, 47/78 (60%) eyes sampled had positive sequencing reads. We observed that half of patients (8/17, 47%) had distinct microbiomes in each eye. Healthy controls had a Lactobacillus/Streptococcus mixture or significant Corynebacterium. Staphylococcus predominated in 4/7 (57%) patients with Stevens-Johnson Syndrome (SJS) in at least one eye, compared to 0/10 healthy controls. Interestingly, 8/11 (73%) eyes with SJS were using BCLs, including 4/5 (80%) eyes dominated by Staphylococcus. Lax eyelid syndrome (LES) and Dry Eye Disease (DED) patients had similar OSMs, with Corynebacterium being the most prevalent bacteria. Alpha diversity was higher in controls and ocular graft-vs-host (oGVHD) patients compared to the other OSDs.

conclusionsOnly 50% of the 39 patients had similar microbiomes in each eye. A majority of healthy eyes had a Lactobacillus/Streptococcus mix or Corynebacterium microbiome. Staphylococcus predominated in SJS, Lactobacillus in oGVHD, and Corynebacterium in DED and LES. There may be an association between different OSDs and the microbiome.

Indexed as

Dry Eye SyndromesEyelid DiseasesMicrobiotaStevens-Johnson SyndromeAdolescentAdultAgedAged, 80 and overChildFemaleHumansMaleMiddle AgedProspective StudiesYoung AdultDry eyeFloppy eyelid syndromeMicrobiomeoGVHDSJS

Identifiers

PMID32717380
PMCPMC7905829
OpenAlexW3044403972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.